News | September 23, 2022
Shilpa Medicare Hyderabad facility receives US FDA clearance
The facility is identified as a testing laboratory in numerous ANDAs filed by Shilpa Medicare Limited and its agreed parties
The facility is identified as a testing laboratory in numerous ANDAs filed by Shilpa Medicare Limited and its agreed parties
Krsnaa Diagnostics plans to set up Tele-Pathology Reporting Centre in Pune
Witnessing sizable consolidation (M& A) activity with Domestic Formulations and Hospitals being two areas wherein maximum M&A has occurred.
Our strategy to drive therapy and brand-focused expansion will continue to show results, especially in the domestic business.
This newly launched institute will be the centre of excellence in the treatment of all cancers under a single roof.
NULIBRY is a first-in-class cPMP substrate replacement therapy to reduce the risk of mortality in patients with MoCD Type A.
Aster Pharmacy will be operated by GD Assist Limited in Bangladesh.
Phase 2 study evaluating an investigational weekly oral combination treatment regimen of islatravir and Gilead Sciences’ lenacapavir to resume with lower dose of islatravir
Coordinated by the Medical University of Vienna, a consortium of 13 leading European organizations including university hospitals, research institutions and healthcare companies will conduct the 5-year project co-funded by Horizon Europe.
Evusheld significantly reduced risk of severe COVID-19 or death in TACKLE Phase III treatment trial
Subscribe To Our Newsletter & Stay Updated
